Quick answers
- What is Actos?
- Actos is a brand name of Pioglitazone, a prescription medicine. The FDA NDC Directory lists 3 Actos products in 3 strengths and forms.
- Who makes Actos?
- Takeda Pharms USA holds the FDA application for Actos (NDA021073, approved July 15, 1999).
- Is there a generic or store brand of Actos?
- Yes. The FDA NDC Directory lists 62 other products with the same active ingredients, strength and form as a Actos product, 62 of them generic. Ask your pharmacist whether one is right for you.
- Has Actos been recalled?
- No recall linked to Actos products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Actos is
Each Actos product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Pioglitazone · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| pioglitazone hydrochloride 15 mg tablet (oral) | Actos | 20 products, 18 companies | DailyMed |
| pioglitazone hydrochloride 30 mg tablet (oral) | Actos | 28 products, 19 companies | DailyMed |
| pioglitazone hydrochloride 45 mg tablet (oral) | Actos | 14 products, 13 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Pioglitazone →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021073 | Takeda Pharms USA | July 15, 1999 | 3 |
Companies that list Actos
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Actos products.
- Takeda Pharmaceuticals America, Inc.3 products
Recalls
No recall linked to Actos products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.